Book Review - Richard Goldberg, Medicinal Product Liability and Regulation (Hart Publishing, Oxford, 2013) 214pp

  • Mabel Tsui Queensland University of Technology

Abstract

In December 2013, settlement was reached between approximately 100 Australian and New Zealand Thalidomide victims and the company which had acted as the Australian distributor of the infamous drug, thus putting to rest the possibility of litigation. Around the same time, Thalidomide victims in the United Kingdom (UK) launched a similar bid for compensation against the manufacturer and distributor. It is clear that despite a lengthy amount of time having passed ever since the thalidomide disaster commenced in 1962, the controversy over compensation continues. Indeed, the author of Medicinal Product Liability and Regulation (published before the announcement of the British legal claim), Professor Goldberg, notes that claims for resulting birth defects continue to emerge right into the present day. His prescient insight into the contemporary relevance of compensation for pharmaceutical injuries thus makes Medicinal Product Liability and Regulation a very relevant addition to the small body of scholarship that is available on this rather specific and complex issue.

Downloads

Total Abstract Views: 895

Published
Dec 17, 2014
How to Cite
TSUI, Mabel. Book Review - Richard Goldberg, Medicinal Product Liability and Regulation (Hart Publishing, Oxford, 2013) 214pp. QUT Law Review, [S.l.], v. 14, n. 2, dec. 2014. ISSN 2201-7275. Available at: <https://lr.law.qut.edu.au/article/view/628>. Date accessed: 20 apr. 2019. doi: https://doi.org/10.5204/qutlr.v14i2.628.

Keywords

Thalidomide; Medicinal Product Liability ; pharmaceutical regulation
Since 2015-12-04
Abstract Views
1165
PDF Views
1122
Until 2015-12-04:
Abstract Views
503
PDF Views
736